Stocktoria
Immunovant, Inc. IMVT
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-05-14
Immunovant, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,916,127 | $129.8M | 2.41% |
| CITADEL ADVISORS LLC | 217,298 | $5.4M | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 192,500 | $4.8M | 0.09% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.